94 related articles for article (PubMed ID: 2805413)
1. Autoimmune kidney disease in MRL/Mp-lpr/lpr mice inhibited by OK-432, a streptococcal preparation.
Mihara M; Ohsugi Y
Clin Exp Immunol; 1989 Oct; 78(1):102-7. PubMed ID: 2805413
[TBL] [Abstract][Full Text] [Related]
2. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
[TBL] [Abstract][Full Text] [Related]
4. 5-Azacytidine inhibits the lpr gene-induced lymphadenopathy and acceleration of lupus-like syndrome in MRL/MpJ-lpr/lpr mice.
Yoshida H; Yoshida M; Merino R; Shibata T; Izui S
Eur J Immunol; 1990 Sep; 20(9):1989-93. PubMed ID: 1698637
[TBL] [Abstract][Full Text] [Related]
5. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
[TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanisms of the development of lupus nephritis in BXSB mice. II. Comparative studies between male BXSB and MRL/lpr mice at the onset period.
Makino M; Fujiwara M; Watanabe H
J Clin Lab Immunol; 1988 Feb; 25(2):83-8. PubMed ID: 3259631
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
Haas C; Ryffel B; Le Hir M
J Immunol; 1997 Jun; 158(11):5484-91. PubMed ID: 9164971
[TBL] [Abstract][Full Text] [Related]
9. Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein.
Rodriguez W; Mold C; Marnell LL; Hutt J; Silverman GJ; Tran D; Du Clos TW
Arthritis Rheum; 2006 Jan; 54(1):325-35. PubMed ID: 16385552
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
Rodgers KE
J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice.
Zavala F; Masson A; Hadaya K; Ezine S; Schneider E; Babin O; Bach JF
J Immunol; 1999 Nov; 163(9):5125-32. PubMed ID: 10528219
[TBL] [Abstract][Full Text] [Related]
13. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
14. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
[TBL] [Abstract][Full Text] [Related]
15. Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506.
Yamamoto K; Mori A; Nakahama T; Ito M; Okudaira H; Miyamoto T
Immunology; 1990 Feb; 69(2):222-7. PubMed ID: 1689694
[TBL] [Abstract][Full Text] [Related]
16. The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice.
Hong YH; Huang CJ; Wang SC; Lin BF
Lupus; 2009 Mar; 18(3):206-15. PubMed ID: 19213858
[TBL] [Abstract][Full Text] [Related]
17. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
Hagiwara E; Okubo T; Aoki I; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Okuda K; Miyazaki J; Ishigatsubo Y
Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249
[TBL] [Abstract][Full Text] [Related]
18. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
[TBL] [Abstract][Full Text] [Related]
19. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
[TBL] [Abstract][Full Text] [Related]
20. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]